Picture of Xbrane Biopharma AB logo

XBRANE — Xbrane Biopharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Xbrane Biopharma Gets Acceptance To Initiate Xlucane Clinical Trial In US

Jan 18 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * REG-XBRANE BIOPHARMA ANNOUNCES ACCEPTANCE OF INITIATION OF
XLUCANE CLINICAL TRIAL IN THE US

Source text for Eikon:  ID:nGNE7SWt5M 
Further company coverage:  XBRANE.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Xbrane Biopharma AB

See all news